Illumina公司股票周二表现逊于竞争对手 - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
生命科学资讯
生物技术与制药领域的最新动态
Illumina的TruPath罕见病计划是否重塑其临床测序投资叙事？
Is Illumina’s (ILMN) TruPath Rare Disease Push Reframing Its Clinical Sequencing Investment Narrative? - simplywall.st
大规模心脏遗传学检测：TruGenome心血管疾病检测与CardioSeq临床试验 - Illumina
Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Illumina公司（ILMN）3月2日交易下跌2.84% - GuruFocus
Illumina Inc (ILMN) Trading Down 2.84% on Mar 2 - GuruFocus
Illumina通过TruPath基因组与FSU协议深化临床基因组学布局——Simplywall.st
Illumina Deepens Clinical Genomics Role With TruPath Genome And FSU Deal - simplywall.st
Illumina公司$ILMN持仓获花旗集团增持 - MarketBeat
Illumina, Inc. $ILMN Position Boosted by Citigroup Inc. - MarketBeat
Illumina股价飙升5.5%，积极前景与多组学战略推动市场动能持续增强
Illumina jumps 5.5% as momentum builds after upbeat outlook and multiomics push - Quiver Quantitative
Illumina与SPT Labtech及Takara Bio合作推进自动化样本制备与空间转录组学技术 - GEN - 基因工程与生物技术新闻
Illumina Partners with SPT Labtech, Takara Bio on Automated Sample Prep and Spatial Transcriptomics - GEN - Genetic Engineering and Biotechnology News
Illumina与SPT Labtech、Takara Bio合作推进自动化样本制备与空间转录组学技术——GEN生物技术新闻
Illumina Partners with SPT Labtech, Takara Bio on Automated Sample Prep and Spatial Transcriptomics - GEN - Genetic Engineering and Biotechnology News
Illumina发布TruPath基因组平台，公布NovaSeq X路线图，并通过连接多组学推动癌症研究突破 - PR Newswire APAC - PR Newswire Asia
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics - PR Newswire APAC - PR Newswire Asia
Illumina：竞争压力加剧但2026年营收目标不变，维持持有评级——TipRanks
Illumina: Competitive Pressures Mounting but 2026 Revenue Targets Still Intact, Justifying a Hold Rating - TipRanks
Illumina全基因组测序技术将加速佛罗里达州罕见病检测进程 - 美通社
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - PR Newswire
佛罗里达实验室运用基因组测序技术诊断儿童罕见疾病 - 股票泰坦
Florida lab uses genome sequencing to diagnose children with rare diseases - Stock Titan
Illumina全基因组测序技术加速佛罗里达州罕见病检测进程 - 雅虎财经
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - Yahoo Finance
Primecap Management Co. CA出售73,220股Illumina公司$ILMN股份
Primecap Management Co. CA Sells 73,220 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina股价表现攀升，相对强度评级跃升至82点 - 投资者商业日报
Illumina Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
Illumina股价表现攀升，相对强度评级跃升至82点——投资者商业日报
Illumina Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
评估Illumina（ILMN）近期股价波动后的估值 - simplywall.st
Assessing Illumina (ILMN) Valuation After Recent Share Price Momentum Shifts - simplywall.st
Illumina推出TruPath基因组，发布NovaSeq X路线图，并通过连接多组学推动癌症研究突破——韩国先驱报
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics - The Korea Herald
新一代正在塑造罕见病的未来 - Illumina
The next generation is shaping the future of rare diseases - Illumina